✓ Graphs ✓ Tables ✓ Reports
 
Format: www.xyz.com or *.gov
Where ▼
Where ▲
Date:
Note: Results will be PDF and Excel – which we can date reliably. For PDFs, it will either be the date the PDF was creater, or the date visible in the graph or chart.
When ▼
When ▲
What ▼
What ▲

Data & statistics on HIV DISEASE AGE-SPECIFIC DEATH RATES – 55 results
Hover over me
Reports the cost-effectiveness results from the model when the age-specific mortality risks are doubled, for HCV/HIV co-infected patients. This would result in an age-specific life expectancy at age 40 of 33.2 years for an HIV infected person (in the absence of chronic liver disease) compared with 39.8 years if the age-specific mortality risks for the general population are applied (as in the base ...

Reports the cost-effectiveness results from the model when the age-specific mortality risks are doubled, for HCV/HIV co-infected patients. This would result in an age-specific life expectancy at age ...

www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf

Table 66 Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2a and ribavirin combination therapy – higher age-specific mortality risks for co-infected patients ...
Table 65 Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2a and ribavirin combination therapy – using higher fibrosis progression probability for co-infected patients Outcome (Life years) Outcome (QALYs) ICER (£ per QALY

Apr 2010 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf
Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2a and ribavirin combination therapy – higher age-specific mortality risks for co-infected patients

Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2a and ribavirin combination therapy – higher age-specific mortality risks for co-infected patients

www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf

specific mortality risks are doubled, for HCV/HIV co-infected patients. This would result in an age-specific life expectancy at age 40 of 33.2 years for an HIV infected person (in the absence of chronic liver disease) compared with 39.8 years if the age ...
of treatment of HCV/HIV co-infected patients with peginterferon α-2a and ribavirin combination therapy – higher age-specific mortality risks for co-infected patients Outcome ...
reduced, with higher mortality risk for HCV/HIV co-infected patients, treatment

Apr 2010 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf
Reports the cost-effectiveness results from the model when the age-specific mortality risks are doubled, for HCV/HIV co-infected patients. This reduces lifetime costs and QALYs both for peginterferon treated and BSC cohorts and would suggest that treatment using peginterferon α-2b and ribavirin combination therapy will be less cost-effective in HCV/HIV co-infected patients, if mortality risk is greater ...

Reports the cost-effectiveness results from the model when the age-specific mortality risks are doubled, for HCV/HIV co-infected patients. This reduces lifetime costs and QALYs both for peginterferon ...

www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf

Table 74 Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2b and ribavirin combination therapy – using higher age-specific mortality risks for co-infected patients ...
Table 73 Cost-effectiveness of treatment of HCV/HIV co-infected patients with peginterferon α-2b and ribavirin combination therapy – using higher fibrosis progression probability for co-infected patients Outcome (Life years) Outcome (QALYs) ICER (£ per QALY

Apr 2010 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/12056/48453/48453.pdf
CVD risk was assumed to rise at the rate of 0.03% pa for men and 0.008% pa for women (estimated from the Health Survey for England data 1998 by ScHARR). The proportion of first CVD events that were MI, stroke or unstable angina were taken from the age-specific, UK incidence rates used in the ScHARR statins model. In the Statins model they obtained their data from the Bromley Coronary Heart Disease ...

CVD risk was assumed to rise at the rate of 0.03% pa for men and 0.008% pa for women (estimated from the Health Survey for England data 1998 by ScHARR). The proportion of first CVD events that were MI ...

www.nice.org.uk/nicemedia/live/10985/30100/30100.pdf

to be fatal (from the ScHARR model). Non-CVD related mortality by age and sex (Table ...
The probabilities of primary CVD events for various age groups (45, 55, 65, 75, 85 year-olds) with initial CVD risk of 2% are shown in The risk of CVD-related mortality was estimated ...
DRAFT FOR CONSULTATION 01 Mortality 0.87 [0.75, 1.01] 02 Myocardial Infarction 0.74 [0.61, 0.91] 03 Stroke 0.62 [0.51, 0.77]

Jan 1998 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/10985/30100/30100.pdf
Number 2.1: Number ofage-specificage-specific mortality rates, Figure of deaths and deaths and mortality rates, colorectal cancer, by sex, UK

Number 2.1: Number ofage-specificage-specific mortality rates, Figure of deaths and deaths and mortality rates, colorectal cancer, by sex, UK

www.nice.org.uk/nicemedia/live/11840/53846/53846.pdf

ofage-specificage-specific mortality rates, Figure of deaths and deaths ...
incidence and mortality rates by cancer, UK, Age standardised incidence and mortality ...
deaths from cancer continued to outnumber deaths from diseases of the circulatory

Jan 2005 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/11840/53846/53846.pdf
Observed and predicted fatality rates from meningococcal disease

Observed and predicted fatality rates from meningococcal disease

www.nice.org.uk/nicemedia/live/11637/45853/45853.pdf

The case fatality rate compared with the PRISM predicted fatality rate by year was reported shown in table 6.5. Table 6.5 Observed and predicted fatality rates from meningococcal disease Observed fatality rate % (n) 22% (10) 13% (5) 11 ...
(n=331). Septicaemia was the principal diagnosis in 281 cases. The case fatality rate compared with the PRISM predicted fatality rate by year was reported shown in table 6.5. ...
specialising in meningococcal disease and a specialist transport service delivering mobile

Jan 2009 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/11637/45853/45853.pdf
Table 1 Age Standardised Incidence and Mortality from Cervical Cancer, England

Table 1 Age Standardised Incidence and Mortality from Cervical Cancer, England

www.nice.org.uk/nicemedia/live/11513/37793/37793.pdf

rates Description of Parameters used in the Model Age-specific progression rates ...
Analysis for Disease Regression Rates (from CIN2 and CIN3) Sensitivity Analysis for Disease Progression Rates Sensitivity Analysis for Improvement in Test Sensitivity

May 2007 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/11513/37793/37793.pdf
Hazard Ratio for Death according to CKD Stage and Age (O’Hare et al. 2006) 129

Hazard Ratio for Death according to CKD Stage and Age (O’Hare et al. 2006) 129

www.nice.org.uk/nicemedia/pdf/CKDConsFullGuideline.pdf

by age and GFR (129 – Table 3). To get the age-specific death rates for the model, these ratios were multiplied with the age-specific death rates for the general population ...
c/e = 5, 720/38, 500 = 0.149 Mortality Age CKD ¾ CKD 5 85+ Table C3. Hazard Ratio ...
• 38, 500 (=d* b) We estimate the Annual progression rate from ESRD to RRT to be Costs Chronic kidney disease: full guideline DRAFT Page 242 of 296 DRAFT

Jan 2006 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/pdf/CKDConsFullGuideline.pdf
Mortality reduction rates and multipliers applied to baseline mortality

Mortality reduction rates and multipliers applied to baseline mortality

www.nice.org.uk/nicemedia/live/13269/62344/62344.pdf

at each age. By applying this non-disease specific life expectancy to each individual ...
in Table 1.9 for each subpopulation and age group were then adjusted using risk reduction rates as published in the literature to account for the effects of the different risk-reducing surgery options on cancer mortality. Risk reduction rates ...
DRAFT FOR CONSULTATION Table 1.10: Mortality reduction rates and multipliers

Jan 2013 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/live/13269/62344/62344.pdf
Chronic obstructive pulmonary disease (COPD) without reversibility.

Chronic obstructive pulmonary disease (COPD) without reversibility.

www.nice.org.uk/nicemedia/pdf/ChronicHeartFailureFullGuideline.pdf

Draft for consultation Draft for consultation  peripheral vascular disease  erectile dysfunction  diabetes mellitus  interstitial pulmonary disease and  There is no upper age limit. [new 2010] Introduce beta-blockers for heart failure in a ‘start ...
vascular disease, then a selective β blocker licensed for heart failure could ...
and mortality. Trade-off between net health benefits and resource use From the 2003

Jan 2010 | Welcome to the National Institute for Health and Clinical Excellence
Original Url: http://www.nice.org.uk/nicemedia/pdf/ChronicHeartFailureFullGuideline.pdf
Related searches: leading causes of death number percentage of deaths canada, age-specific cervical cancer mortality rates per 100000 women, cancer incidence and mortality, aids related opportunistic infections, deaths from cervical cancer and maternal mortality in developing countries

Hints & help

Language. English only please... for now.
Phrase search. You can use double quotes to make phrases (e.g. "mobile phones").
Booleans. You can use a plus ‘+’ to make a word mandatory, or a minus ‘–‘ to exclude it (e.g. +gas –oil production)
Vocabulary. We have only limited synonyms - please try different words in your query.
Questions? Please email us: helpdesk [at] zanran [dot] com